Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Corral

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Leukemia|January 9, 2015
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolutionN Puig, I Conde, C Jiménez, et al.
Tissue Antigens|April 10, 2008
The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent diseaseM Alcoceba, L Marín, A Balanzategui, et al.
Leukemia|March 1, 2013
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemiaC Jiménez, E Sebastián, M C Chillón, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Leukemia|January 9, 2015
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolutionN Puig, I Conde, C Jiménez, et al.
Tissue Antigens|April 10, 2008
The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent diseaseM Alcoceba, L Marín, A Balanzategui, et al.
Leukemia|March 1, 2013
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemiaC Jiménez, E Sebastián, M C Chillón, et al.
Pageof 4